Roger S. Newton, Director at Esperion Therapeutics, Inc. (ESPR), sold 9,044 shares at $73.26 ($663K) on 2018-03-29, disclosed to the SEC on 2018-03-29.
Open-market sale of $663k ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ESPR | SELL | 2018-10-18 | $1.7M | — | Filing → |
| ESPR | SELL | 2018-08-29 | $904K | — | Filing → |
| ESPR | SELL | 2018-08-22 | $365K | — | Filing → |